Image

Global Q-PCR and D-PCR Devices Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Upcoming Report
  • Apr 2021
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220
  • Healthcare
  • Upcoming Report
  • Apr 2021
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Q-PCR and D-PCR Devices Market, By Technology (Quantitative PCR, Digital PCR), Products and Services (Reagents, Consumables, Instruments and Software), Application (Clinical Applications, Research, Forensic and Others), End User (Hospitals, Diagnostic Centres, Research Laboratories, Academic Institutes, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations and Forensic Laboratories), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Q-PCR and D-PCR Devices Market Market Analysis and Insights of Q-PCR and D-PCR Devices Market

The rising prevalence of genetic disorders and target infectious diseases has propelled the growth in demand for Q-PCR and D-PCR devices. Data Bridge Market Research analyses that the Q-PCR and D-PCR devices market will project a CAGR of 9.05% for the forecast period of 2021-2028.

Quantitative Polymerase Chain Reaction (qPCR) is a technology that is used to measure DNA using PCR. In simpler words, it is a molecular laboratory technology that is used to monitor the amplification of DNA molecule during PCR. Digital Polymerase Chain Reaction (dPCR) is a technology that is used to measure the amount of DNA and RNA in a sample. It is a biotechnology that is used to quantify the target nucleic acids.

Rising genetic disorders coupled with target infectious diseases will drive the growth in demand for Q-PCR and D-PCR devices. Increased research and expenditure on the PCR technology and increased investment will further create more opportunities for the growth of Q-PCR and D-PCR devices market. A shift from plant-derived to genome-based drug discovery will further propel market growth. Wide range of applications offered by qPCR and dPCR technology will further broaden the scope of growth for the market.

High costs involved in the acquisition of the technology will hamper the growth of the market. Also, limitations of this technology will slow down the rate of market growth. Dearth of skilled professionals and trained expertise will again hammer down the market growth rate. Rising adoption of guidelines will pose another threat to the market growth.

This Q-PCR and D-PCR devices market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info Q-PCR and D-PCR devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Q-PCR and D-PCR Devices Market Scope and Market Size

The Q-PCR and D-PCR devices market is segmented on the basis of technology, products and services, application and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of technology, the Q-PCR and D-PCR devices market is segmented into quantitative PCR and digital PCR.
  • Based on products and services, the Q-PCR and D-PCR devices market is segmented into reagents, consumables, instruments and software.
  • Based on application, the Q-PCR and D-PCR devices market is segmented into clinical applications, research, forensic and others. Clinical applications have been further segmented into pathogen testing, oncology testing, blood screening and others.
  • The Q-PCR and D-PCR devices market is also segmented on the basis of end user into hospitals, diagnostic centers, research laboratories, academic institutes, pharmaceutical and biotechnology companies, clinical research organizations and forensic laboratories.

Q-PCR and D-PCR Devices Market Country Level Analysis

The Q-PCR and D-PCR devices market is analysed and market size insights and trends are provided by country, technology, products and services, application and end user as referenced above.

The countries covered in the Q-PCR and D-PCR devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been dominating the Q-PCR and D-PCR devices market and will continue to witness a substantial growth for the forecast period. This is because of the prevalence of high demand for quick diagnostic tests, and increased adoption of genomic analysis products. Asia-Pacific on the other hand will witness the highest CAGR for the forecast period. Rise in the number of patients with chronic ailments and improving healthcare infrastructure especially in the developing countries will induce the market growth in this region.

The country section of the Q-PCR and D-PCR devices market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Q-PCR and D-PCR devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for Q-PCR and D-PCR devices market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the digital health technologies market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Q-PCR and D-PCR Devices Market Share Analysis

The Q-PCR and D-PCR devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Q-PCR and D-PCR devices market.

The major players covered in the Q-PCR and D-PCR devices market report are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., QIAGEN, Takara Bio Inc., Agilent Technologies, Inc., bioMérieux SA, Danaher., Abbott., Merck KGaA,, BD., Promega Corporation., Eppendorf AG, Analytik Jena GmbH, Meridian Bioscience, Inc., Enzo Life Sciences, Inc., Cole-Parmer Instrument Company, LLC., BIONEER CORPORATION., ELITechGroup and Quantabio among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.


SKU-
Why Choose Us


Frequently Asked Questions